Antonio Díaz‐López

1.1k total citations
15 papers, 682 citations indexed

About

Antonio Díaz‐López is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Antonio Díaz‐López has authored 15 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Antonio Díaz‐López's work include Cancer Cells and Metastasis (4 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Antonio Díaz‐López is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Antonio Díaz‐López collaborates with scholars based in Spain and United States. Antonio Díaz‐López's co-authors include Amparo Cano, Gema Moreno‐Bueno, Manuel Benito, Carmen de Juan, Pilar Iniesta, Cristina García-Aranda, Andrés Sánchez-Pernaute, Alberto Morán, J.L. Balibrea and José Palacios and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Antonio Díaz‐López

15 papers receiving 674 citations

Peers

Antonio Díaz‐López
Ira Kogan Israel
Karina L. Conkrite United States
Hyo-Sung Jeon South Korea
Isil Guney United States
Wai Kei Kwok Hong Kong
Fang Zhu China
Hilda Martinez-Diaz United States
Robert J. Rounbehler United States
Ira Kogan Israel
Antonio Díaz‐López
Citations per year, relative to Antonio Díaz‐López Antonio Díaz‐López (= 1×) peers Ira Kogan

Countries citing papers authored by Antonio Díaz‐López

Since Specialization
Citations

This map shows the geographic impact of Antonio Díaz‐López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Díaz‐López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Díaz‐López more than expected).

Fields of papers citing papers by Antonio Díaz‐López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Díaz‐López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Díaz‐López. The network helps show where Antonio Díaz‐López may publish in the future.

Co-authorship network of co-authors of Antonio Díaz‐López

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Díaz‐López. A scholar is included among the top collaborators of Antonio Díaz‐López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Díaz‐López. Antonio Díaz‐López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mata, Elena, Antonio Díaz‐López, Ana M. Martín‐Moreno, et al.. (2017). Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets. Oncotarget. 8(67). 111386–111395. 27 indexed citations
2.
Martı́nez, Carmen, Antonio Díaz‐López, Mercedes Rodrı́guez-Calvillo, et al.. (2016). Phase II trial of ofatumumab plus ESHAP (O‐ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first‐line chemotherapy. British Journal of Haematology. 174(6). 859–867. 11 indexed citations
3.
Cano, Amparo, Antonio Díaz‐López, & Gema Moreno‐Bueno. (2014). Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Management and Research. 6. 205–205. 147 indexed citations
4.
Barbazán, Jorge, Laura Muinelo‐Romay, María Vieito, et al.. (2014). A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer. International Journal of Cancer. 135(11). 2633–2643. 53 indexed citations
5.
Díaz‐López, Antonio, Juan Díaz‐Martín, Gema Moreno‐Bueno, et al.. (2014). Zeb1 and Snail1 engage miR‐200f transcriptional and epigenetic regulation during EMT. International Journal of Cancer. 136(4). E62–73. 54 indexed citations
6.
Cubillo, Eva, Antonio Díaz‐López, Eva P. Cuevas, et al.. (2013). E47 and Id1 Interplay in Epithelial-Mesenchymal Transition. PLoS ONE. 8(3). e59948–e59948. 45 indexed citations
7.
Díaz‐Martín, Juan, Antonio Díaz‐López, Gema Moreno‐Bueno, et al.. (2013). A core microRNA signature associated with inducers of the epithelial‐to‐mesenchymal transition. The Journal of Pathology. 232(3). 319–329. 57 indexed citations
8.
Díaz‐López, Antonio, Krisztina Tar, Undine Krügel, et al.. (2011). Proteasomal degradation of Sfp1 contributes to the repression of ribosome biogenesis during starvation and is mediated by the proteasome activator Blm10. Molecular Biology of the Cell. 22(5). 528–540. 34 indexed citations
9.
Díaz‐López, Antonio, Pilar Iniesta, Alberto Morán, et al.. (2010). Expression of Human MDGA1 Increases Cell Motility and Cell-Cell Adhesion and Reduces Adhesion to Extracellular Matrix Proteins in MDCK Cells. Cancer Microenvironment. 4(1). 23–32. 11 indexed citations
10.
Morán, Alberto, Andrés Sánchez-Pernaute, Pilar Iniesta, et al.. (2007). Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma.. PubMed. 54(73). 315–9. 25 indexed citations
11.
Iniesta, Pilar, Alberto Morán, Carmen de Juan, et al.. (2007). Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer. Oncology Reports. 17(1). 217–23. 61 indexed citations
12.
Díaz‐López, Antonio, Carmen Rivas, Pilar Iniesta, et al.. (2005). Characterization of MDGA1, a novel human glycosylphosphatidylinositol-anchored protein localized in lipid rafts. Experimental Cell Research. 307(1). 91–99. 16 indexed citations
13.
Morán, Alberto, Pilar Iniesta, Carmen de Juan, et al.. (2005). Impairment of Stromelysin-1 Transcriptional Activity by Promoter Mutations in High Microsatellite Instability Colorectal Tumors. Cancer Research. 65(9). 3811–3814. 26 indexed citations
14.
Morán, Alberto, Pilar Iniesta, Cristina García-Aranda, et al.. (2005). Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer. Oncology Reports. 13(1). 115–20. 31 indexed citations
15.
García-Aranda, Cristina, Carmen de Juan, Antonio Díaz‐López, et al.. (2005). Correlations of telomere length, telomerase activity, and telomeric‐repeat binding factor 1 expression in colorectal carcinoma. Cancer. 106(3). 541–551. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026